CapitaLand Investment's headline patmi rises 165% y-o-y in FY2024; to give dividend-in-specie of CICT units

The Edge Singapore
02-26

CapitaLand Investment has posted a 165% y-o-y surge in headline patmi due to divestments and plans a new dividend policy of 50% payout from cash patmi.

CapitaLand Investment (CLI) has posted a total patmi of $479 million for FY2024, up 165% y-o-y.

However, operating patmi for FY2024 fell 10% y-o-y to $510 million, mainly due to absence of contribution from divested properties as CLI continues its asset-light strategy. CLI generated net portfolio gains of $230 million from divestments. 

Revenue for FY2024 was $2,815 million, with fee-related business (FRB) revenue growing by 9% y-o-y to $1,169 million, supported by increases in revenue contribution from all four FRB segments: Listed Funds Management, Private Funds Management, Lodging Management and Commercial Management.  

Private funds management recorded an increase of 10%. Ebitda for FY2024 rose by 29% y-o-y to $1,421 million. CLI’s funds under management (FUM) grew to $117 billion. CLI attracted more than $3.3 billion in investments across its listed and private funds platforms.  

Divestments totalled $5.5 billion, with its balance sheet assets falling from $8.6 billion as at end-2023 to $4.3 billion as at end-2024. CLI also made $5.4 billion of investments across the group in 2024, including $450 million deployed into strategic mergers and acquisitions (M&A). The lodging business had a record number of openings, with about 11,700 units opened in 54 properties, with RevPAU increasing by 6% y-o-y.
CLI plans to pay a core dividend of 12 cents per share and a special dividend-in-specie of 0.031 CapitaLand Integrated Commercial Trust C38u C38u (CICT) units per share valued at about 6 cents for FY2024, bringing the total dividend to about 18 cents. The total payout is approximately $904 million.
In addition, CLI is proposing to increase its annual dividend to a minimum of 50% of cash patmi to enhance shareholder returns.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10